243 related articles for article (PubMed ID: 10537314)
41. Urokinase signal transduction and its role in cell migration.
Carlin SM; Resink TJ; Tamm M; Roth M
FASEB J; 2005 Feb; 19(2):195-202. PubMed ID: 15677342
[TBL] [Abstract][Full Text] [Related]
42. Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells.
Hapke S; Kessler H; Arroyo de Prada N; Benge A; Schmitt M; Lengyel E; Reuning U
J Biol Chem; 2001 Jul; 276(28):26340-8. PubMed ID: 11331280
[TBL] [Abstract][Full Text] [Related]
43. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.
Waltz DA; Natkin LR; Fujita RM; Wei Y; Chapman HA
J Clin Invest; 1997 Jul; 100(1):58-67. PubMed ID: 9202057
[TBL] [Abstract][Full Text] [Related]
44. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin.
Kjøller L; Hall A
J Cell Biol; 2001 Mar; 152(6):1145-57. PubMed ID: 11257116
[TBL] [Abstract][Full Text] [Related]
45. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
Thomas S; Chiriva-Internati M; Shah GV
Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
[TBL] [Abstract][Full Text] [Related]
46. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
Gargiulo L; Longanesi-Cattani I; Bifulco K; Franco P; Raiola R; Campiglia P; Grieco P; Peluso G; Stoppelli MP; Carriero MV
J Biol Chem; 2005 Jul; 280(26):25225-32. PubMed ID: 15866865
[TBL] [Abstract][Full Text] [Related]
47. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
[TBL] [Abstract][Full Text] [Related]
48. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma.
Pyke C; Graem N; Ralfkiaer E; Rønne E; Høyer-Hansen G; Brünner N; Danø K
Cancer Res; 1993 Apr; 53(8):1911-5. PubMed ID: 8385573
[TBL] [Abstract][Full Text] [Related]
49. Vitronectin is responsible for serum-stimulated uptake of rod outer segments by cultured retinal pigment epithelial cells.
Miceli MV; Newsome DA; Tate DJ
Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1588-97. PubMed ID: 9224287
[TBL] [Abstract][Full Text] [Related]
50. Modeling the influence of ectodomain affinities on the spatial distribution of membrane receptors.
Weinand RG; Rosenspire AJ; Petty HR
J Theor Biol; 1999 Mar; 197(2):217-25. PubMed ID: 10074395
[TBL] [Abstract][Full Text] [Related]
51. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells.
Simon DI; Rao NK; Xu H; Wei Y; Majdic O; Ronne E; Kobzik L; Chapman HA
Blood; 1996 Oct; 88(8):3185-94. PubMed ID: 8874219
[TBL] [Abstract][Full Text] [Related]
52. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.
Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM
Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of alphavbeta5 integrin activation.
Vocca I; Franco P; Alfano D; Votta G; Carriero MV; Estrada Y; Caputi M; Netti PA; Ossowski L; Stoppelli MP
Int J Cancer; 2009 Jan; 124(2):316-25. PubMed ID: 18844213
[TBL] [Abstract][Full Text] [Related]
54. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and beta2-integrins.
Chavakis T; May AE; Preissner KT; Kanse SM
Blood; 1999 May; 93(9):2976-83. PubMed ID: 10216093
[TBL] [Abstract][Full Text] [Related]
55. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions.
Chavakis T; Kanse SM; Lupu F; Hammes HP; Müller-Esterl W; Pixley RA; Colman RW; Preissner KT
Blood; 2000 Jul; 96(2):514-22. PubMed ID: 10887113
[TBL] [Abstract][Full Text] [Related]
56. Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro.
Heyman L; Kellouche S; Fernandes J; Dutoit S; Poulain L; Carreiras F
Tumour Biol; 2008; 29(4):231-44. PubMed ID: 18781095
[TBL] [Abstract][Full Text] [Related]
57. Regulation of integrin function by the urokinase receptor.
Wei Y; Lukashev M; Simon DI; Bodary SC; Rosenberg S; Doyle MV; Chapman HA
Science; 1996 Sep; 273(5281):1551-5. PubMed ID: 8703217
[TBL] [Abstract][Full Text] [Related]
58. The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.
Montuori N; Bifulco K; Carriero MV; La Penna C; Visconte V; Alfano D; Pesapane A; Rossi FW; Salzano S; Rossi G; Ragno P
Cell Mol Life Sci; 2011 Jul; 68(14):2453-67. PubMed ID: 20972812
[TBL] [Abstract][Full Text] [Related]
59. Plasmin abrogates alpha v beta 5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin.
Reinartz J; Schäfer B; Batrla R; Klein CE; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):274-82. PubMed ID: 7556434
[TBL] [Abstract][Full Text] [Related]
60. uPAR-induced cell adhesion and migration: vitronectin provides the key.
Madsen CD; Ferraris GM; Andolfo A; Cunningham O; Sidenius N
J Cell Biol; 2007 Jun; 177(5):927-39. PubMed ID: 17548516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
